Analysis of liver disease in europe

Based on drugs, the global fatty liver treatment market is divided into following: An empirical database on mortality due to liver cirrhosis was collated using primarily vital registration data.

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

J Nutr Intermed Metab ;5: European countries must do more to promote a reduction in alcohol consumption and to reduce levels of obesity. Methods Overview Our aim was to estimate annual liver cirrhosis mortality levels, patterns, and temporal trends between and for countries covering The major companies covered under the scope of the study are Gilead Science Inc.

Data on liver risk factors were collected by questionnaire, and by measurement of body height, weight obesityand hepatitis B surface antigen HBsAg. Treatment approaches, including availability of medications, models of care, and approach to transplantation, differ among regions.

Changing lifestyle such as increasing consumption of alcohol, unhealthy diets have increased the incidences of liver disease.

The drug type segment is further sub-segmented in vaccines, antiviral, corticosteroids, anabolic steroids, antimetabolites, anti-rejection drugs, immunosuppressive agents, immune globulins and chemotherapy.

The global health community has increasingly recognized the importance of controlling liver cirrhosis risk factors, particularly heavy alcohol intake and chronic viral hepatitis B and C infections. Fatty Liver Treatment Market: However, side-effects and risk associated with medications impede growth of the liver disease treatment market.

Depending on information available on the death certificate, a specific cause of death is assigned, for example, alcoholic cirrhosis of the liver, or a more general code can only be assigned, for example, unspecified cirrhosis of the liver.

Our portfolio is organized into five segments: Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent. Moreover, due to the low cost of generic drugs compared to the branded therapies, there is more preference towards generic drugs or bio similar drugs for the treatment of various diseases.

Frequency rates of risk factors for liver disease among subjects with obesity were significantly higher in the female patient group, and the frequency rate among subjects with alcoholic drinking habits was significantly higher in the male patient group.

While NASH can reverse itself, in many cases, the resulting liver scarring causes a patient's liver to harden and failure to work properly.

In Egypt, almost one-fifth Whereas, growing geriatric population has lead to significant addition in the global liver disease treatment market. The Commission will quantify the burden of liver disease in Europe, and will examine evidence-based health policies that can reduce liver deaths and health inequities, alongside increasing government revenues for health systems dealing with liver diseases.

To survey the burden of liver disease in Europe and its causes epidemiological studies published in the last five years were reviewed.

Fatty liver disease

The incidence and prevalence of cirrhosis and primary liver cancer are key to understand the burden of liver Liver Disease Treatment Market Overview: Global Liver Disease Treatment Market is expected to garner $19, million byregistering a CAGR of % during the forecast period - Liver disease comprises of wide range of complex conditions affecting the liver.

Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. · The Burden of Liver Disease in Europe: A Review of Available Epidemiological Date reviews epidemiological studies published in the last five years to survey the current state of evidence on the burden of liver disease in Europe and its  · Tackling chronic disease in Europe The European Observatory on Health Systems and Policies supports and promotes evidence- based health policy-making through comprehensive and rigorous analysis of health systems  · Alcoholic liver disease is damage to the liver and its function due to alcohol abuse.

Your Shopping Cart Is Empty

28 • Alcoholic liver disease is the most prevalent cause of advanced liver disease in Europe 29 • ALD is the most common cause of cirrhosis in the Western world and one of the ten

Analysis of liver disease in europe
Rated 3/5 based on 46 review
Fatty liver disease - Wikipedia